tiprankstipranks
Appili Therapeutics Inc Class A (TSE:APLI)
TSX:APLI
Holding TSE:APLI?
Track your performance easily

Appili Therapeutics Inc Class A (APLI) Financial Statements

22 Followers

Appili Therapeutics Inc Class A Financial Overview

Appili Therapeutics Inc Class A's market cap is currently ―. The company's EPS TTM is C$-0.029; its P/E ratio is -1.18; Appili Therapeutics Inc Class A is scheduled to report earnings on February 18, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-C$ 11.70KC$ 478.40KC$ 337.31K-
Gross Profit-C$ 11.70KC$ 478.40KC$ 337.31K-
EBITC$ -353.81KC$ -711.59KC$ 292.38KC$ -506.34KC$ -1.45M
EBITDAC$ -350.44KC$ -708.20KC$ 295.77KC$ -502.90KC$ -1.44M
Net Income Common StockholdersC$ -1.58MC$ -1.10MC$ -152.34KC$ -976.55KC$ -1.84M
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 301.26KC$ 94.49KC$ 602.88KC$ 395.62KC$ 520.59K
Total AssetsC$ 2.23MC$ 1.49MC$ 1.97MC$ 1.96MC$ 2.17M
Total DebtC$ 10.05MC$ 8.18MC$ 8.01MC$ 8.00MC$ 7.69M
Net DebtC$ 9.75MC$ 8.09MC$ 7.41MC$ 7.61MC$ 7.17M
Total LiabilitiesC$ 14.62MC$ 12.42MC$ 11.80MC$ 11.65MC$ 10.94M
Stockholders EquityC$ -12.39MC$ -10.92MC$ -9.83MC$ -9.70MC$ -8.77M
Cash Flow-
Free Cash FlowC$ -132.07KC$ -456.03KC$ 253.24KC$ -237.14KC$ -2.05M
Operating Cash FlowC$ -132.07KC$ -456.69KC$ 253.24KC$ -237.14KC$ -2.02M
Investing Cash Flow-C$ 654.00--C$ -29.72K
Financing Cash FlowC$ 338.43KC$ -51.37KC$ -45.88KC$ 111.72KC$ 107.58K
Currency in CAD

Appili Therapeutics Inc Class A Earnings and Revenue History

Appili Therapeutics Inc Class A Debt to Assets

Appili Therapeutics Inc Class A Cash Flow

Appili Therapeutics Inc Class A Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis